• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用编织4F选择性导管进行常见身体介入操作的无鞘血管通路安全性——一项回顾性研究

Safety of sheathless vascular access using braided 4 F selective catheters for common body interventions - a retrospective study.

作者信息

Nadjiri Jonathan, Geith Tobias, Mühlmann Marc, Waggershauser Tobias, Paprottka Philipp M

机构信息

Department of Interventional Radiology, School of medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, DE, Germany.

出版信息

CVIR Endovasc. 2023 Feb 16;6(1):6. doi: 10.1186/s42155-023-00350-5.

DOI:10.1186/s42155-023-00350-5
PMID:36795179
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9935754/
Abstract

BACKGROUND

Besides other factors, complication rate of transarterial interventions depends on the size of the vascular access. Therefore, the vascular access is mostly chosen as small as possible while still allowing all planned parts of the intervention. This retrospective analysis is to evaluate the safety and feasibility of sheathless arterial interventions for a broad spectrum of interventions in daily practice.

METHODS

All sheathless interventions using a 4 F main catheter between May 2018 and September 2021 were included in the evaluation. Additionally, intervention parameters such as type of catheter, use of microcatheter and required change of main catheters were assessed. Information about the use about sheathless approach and catheters were obtained from the material registration system. All catheters were braided.

RESULTS

503 sheathless interventions with 4 F catheters from the groin were documented. The spectrum comprised bleeding embolization, diagnostic angiographies, arterial DOTA-TATE-therapy, uterine fibroid embolization, transarterial chemotherapy, transarterial radioembolization and others. In 31 cases (6 %) a change of the main catheter was required. In 381 cases (76 %) a microcatheter was utilized. No clinically relevant adverse events were observed (grade 2 or higher [CIRSE AE-classification]). None of the cases later required conversion to a sheath-based intervention.

CONCLUSIONS

Sheathless interventions with a 4 F braided catheter from the groin are safe and feasible. It allows for a broad spectrum of interventions in daily practice.

摘要

背景

除其他因素外,经动脉介入治疗的并发症发生率取决于血管通路的大小。因此,在仍能进行所有计划中的介入治疗部分的情况下,血管通路大多选择尽可能小。本回顾性分析旨在评估在日常实践中,无鞘动脉介入治疗对广泛的介入治疗的安全性和可行性。

方法

评估2018年5月至2021年9月期间所有使用4F主导管的无鞘介入治疗。此外,还评估了介入参数,如导管类型、微导管的使用以及主导管所需的更换情况。关于无鞘方法和导管使用的信息从材料登记系统中获取。所有导管均为编织型。

结果

记录了503例经腹股沟使用4F导管的无鞘介入治疗。治疗范围包括出血栓塞、诊断性血管造影、动脉DOTA-TATE治疗、子宫肌瘤栓塞、经动脉化疗、经动脉放射性栓塞等。31例(6%)需要更换主导管。381例(76%)使用了微导管。未观察到临床相关不良事件(2级或更高[CIRSE不良事件分类])。所有病例后期均无需转换为基于鞘管的介入治疗。

结论

经腹股沟使用4F编织导管进行无鞘介入治疗是安全可行的。它在日常实践中允许进行广泛的介入治疗。

相似文献

1
Safety of sheathless vascular access using braided 4 F selective catheters for common body interventions - a retrospective study.使用编织4F选择性导管进行常见身体介入操作的无鞘血管通路安全性——一项回顾性研究
CVIR Endovasc. 2023 Feb 16;6(1):6. doi: 10.1186/s42155-023-00350-5.
2
All comers 5 French transfemoral percutaneous coronary intervention without sheath.所有人行 5 French 经股动脉逆行冠状动脉介入治疗,无需鞘管。
Catheter Cardiovasc Interv. 2011 Jul 1;78(1):47-51. doi: 10.1002/ccd.22853. Epub 2011 Mar 16.
3
[Multicentric experience with the use of Sheathless 6.5 French-size catheter in coronary angioplasty for bifurcation lesions: feasibility and safety].[无鞘6.5法国规格导管在冠状动脉分叉病变血管成形术中应用的多中心经验:可行性与安全性]
Ann Cardiol Angeiol (Paris). 2012 Dec;61(6):405-12. doi: 10.1016/j.ancard.2012.09.012. Epub 2012 Oct 3.
4
Feasibility and safety of transradial coronary interventions using a 6.5-F sheathless guiding catheter in patients with small radial arteries.在桡动脉细小的患者中使用6.5F无鞘导引导管进行经桡动脉冠状动脉介入治疗的可行性和安全性。
Catheter Cardiovasc Interv. 2015 Jul;86(1):51-8. doi: 10.1002/ccd.25508. Epub 2015 Mar 30.
5
Access-site complications of transradial percutaneous coronary intervention using sheathless guiding catheters for acute coronary syndrome: a prospective cohort study with radial ultrasound follow-up.经桡动脉途径使用无鞘引导导管行直接经皮冠状动脉介入治疗急性冠状动脉综合征的入路部位并发症:一项前瞻性队列研究并桡动脉超声随访。
Cardiovasc Interv Ther. 2020 Oct;35(4):343-352. doi: 10.1007/s12928-019-00632-7. Epub 2019 Dec 6.
6
Use of the sheathless guide catheter during routine transradial percutaneous coronary intervention: a feasibility study.鞘内无导引导管在常规经桡动脉经皮冠状动脉介入治疗中的应用:一项可行性研究。
Catheter Cardiovasc Interv. 2010 Mar 1;75(4):596-602. doi: 10.1002/ccd.22246.
7
4Fr in 5Fr sheathless technique with standard catheters for transradial coronary interventions: technical challenges and persisting issues.用于经桡动脉冠状动脉介入治疗的采用标准导管的4Fr对5Fr无鞘技术:技术挑战与持续存在的问题
Catheter Cardiovasc Interv. 2015 Apr;85(5):809-15. doi: 10.1002/ccd.25709. Epub 2014 Nov 1.
8
Usefulness of sheathless guiding catheters in patients with upper extremity vascular anomalies: Sheathless catheters in upper vascular anomalies.无鞘引导导管在患有上肢血管异常患者中的应用:上肢血管异常中的无鞘导管
AsiaIntervention. 2020 Jul;6(1):43-49. doi: 10.4244/AIJ-D-19-00024. Epub 2020 Jul 20.
9
Evaluation of Railway Sheathless Access System for Transradial Coronary and Peripheral Interventions.经桡动脉冠状动脉及外周介入治疗的铁路无鞘接入系统评估
Cardiovasc Revasc Med. 2021 Jan;22:91-97. doi: 10.1016/j.carrev.2020.06.016. Epub 2020 Jun 15.
10
Sheathless guide catheter in transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction.无鞘导引导管在经桡动脉行经皮冠状动脉介入治疗ST段抬高型心肌梗死中的应用
Catheter Cardiovasc Interv. 2016 May;87(6):1111-7. doi: 10.1002/ccd.26144. Epub 2015 Sep 10.

引用本文的文献

1
Genicular Artery Embolization in Moderate to Severe Knee Osteoarthritis: Technique, Safety and Clinical Outcome.中度至重度膝骨关节炎的膝动脉栓塞术:技术、安全性及临床疗效
Cardiovasc Intervent Radiol. 2025 Mar;48(3):340-350. doi: 10.1007/s00270-025-03983-2. Epub 2025 Feb 19.

本文引用的文献

1
Percutaneous treatment of vascular access-site complications: a ten years' experience in two centres.经皮治疗血管穿刺部位并发症:两个中心的十年经验
CVIR Endovasc. 2020 Jun 8;3(1):29. doi: 10.1186/s42155-020-00120-7.
2
Are complication rates lower with 4-Fr versus 6-Fr transfemoral arterial access - prospective audit at a single interventional radiology centre.4Fr与6Fr经股动脉入路的并发症发生率是否更低——在单一介入放射学中心进行的前瞻性审计
CVIR Endovasc. 2018;1(1):15. doi: 10.1186/s42155-018-0022-4. Epub 2018 Aug 23.
3
Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System.Cirse并发症分类的质量保证文件和标准:Cirse分类系统。
Cardiovasc Intervent Radiol. 2017 Aug;40(8):1141-1146. doi: 10.1007/s00270-017-1703-4. Epub 2017 Jun 5.
4
5-Fr sheathless transradial cardiac catheterization using conventional catheters and balloon assisted tracking; a new approach to downsizing.使用传统导管和球囊辅助追踪技术的5F无鞘经桡动脉心脏导管插入术;一种缩小尺寸的新方法。
Cardiovasc Revasc Med. 2017 Jan-Feb;18(1):28-32. doi: 10.1016/j.carrev.2016.09.003. Epub 2016 Sep 18.
5
Transradial and transulnar access for iliac artery interventions using sheathless guiding systems: A feasibility study.使用无鞘引导系统经桡动脉和尺动脉途径进行髂动脉介入治疗:一项可行性研究。
Catheter Cardiovasc Interv. 2016 Nov 15;88(6):923-931. doi: 10.1002/ccd.26592. Epub 2016 Jun 3.
6
The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access: The Campeau Radial Paradox.经桡动脉入路行冠状动脉造影术的获益被股动脉入路时血管入路部位并发症发生率增加所抵消:坎普桡动脉悖论。
JACC Cardiovasc Interv. 2015 Dec 21;8(14):1854-64. doi: 10.1016/j.jcin.2015.07.029. Epub 2015 Nov 18.
7
Complications related to femoral artery access for transcatheter procedures.经导管手术中与股动脉穿刺相关的并发症。
Vasc Endovascular Surg. 2012 Nov;46(8):617-23. doi: 10.1177/1538574412457475. Epub 2012 Sep 11.
8
The Leipzig prospective vascular ultrasound registry in radial artery catheterization: impact of sheath size on vascular complications.莱比锡前瞻性桡动脉导管置管血管超声登记研究:鞘管大小对血管并发症的影响。
JACC Cardiovasc Interv. 2012 Jan;5(1):36-43. doi: 10.1016/j.jcin.2011.08.011.
9
Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention.接受经皮冠状动脉介入治疗的患者中,采用出血预防策略与围术期出血风险之间的关系。
JAMA. 2010 Jun 2;303(21):2156-64. doi: 10.1001/jama.2010.708.
10
Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005.经皮冠状动脉介入治疗后主要股动脉出血并发症:1994年至2005年在梅奥诊所接受治疗的17901例患者的发生率、预测因素及其对长期生存的影响。
JACC Cardiovasc Interv. 2008 Apr;1(2):202-9. doi: 10.1016/j.jcin.2007.12.006.